Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: Haemostasis parameters of a randomized controlled open labelled trial

British Journal of Anaesthesia

Volumn 116, Issue 5, 2016, Pages 641-648

  Ducloy Bouthors, A S ^a   Duhamel, A ^a,b   Kipnis, E ^a   Tournoys, A ^a,b   Prado Dupont, A ^b,c   Elkalioubie, A ^b   Jeanpierre, E ^a,b   Debize, G ^d   Peynaud Debayle, E ^e   Deprost, D ^e,f   Huissoud, C ^d   Rauch, A ^a,b   Susen, S ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c CENTRE HOSPITALIER DE VALENCIENNES   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e HÔPITAL LOUIS MOURIER   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

fibrinogen; fibrinolysis; postpartum haemorrhage; tranexamic acid

Indexed keywords

ANTIPLASMIN; BLOOD CLOTTING FACTOR 5; D DIMER; FIBRINOGEN; PLASMIN; PROTHROMBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); POST HOC ANALYSIS; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VAGINAL DELIVERY; BLOOD; BLOOD SAMPLING; CLINICAL TRIAL; DRUG EFFECT; METABOLISM; MULTICENTER STUDY; PREGNANCY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION FACTORS; BLOOD SPECIMEN COLLECTION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; SINGLE-BLIND METHOD; TRANEXAMIC ACID;

EID: 84965111163     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aew021     Document Type: Article

References (41)

1. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, 1980-2008: A systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010; 375: 1609-23
2. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: A review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009; 9: 55: 1-10
3. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 2011; 37: 1816-25
4. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; 3: CD001886
5. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2011; 376: 23-32
6. Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood loos: A randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi 2001; 36: 590-2
7. Gai M, Wu L, Su Q, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: A multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004; 112: 154-7
8. Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet 2011; 115: 224-6
9. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 2009; 22: 72-5
10. Xu J, GaoW, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: A double-blind randomization trial. Arch Gynecol Obstet 2013; 287: 463-68
11. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15: R117
12. Kojima T, Gando S, Morimoto Y, et al. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Thromb Res 2001; 104: 301-7
13. Erez O, Novack L, Beer-Weisel R, et al. DIC score in pregnant women-A population based modification of the International Society on Thrombosis and Hemostasis score. PLoS ONE 2014; 9: e93240
14. Levy G, Goffinet F, Carbonne B, et al. Recommandations pour la pratique Clinique Hémorragies du post-partum immediate. J Gynecol Obstet Biol Reprod 2004; 33: S8. [http://www.hassante. fr/portail/upload/docs/application/pdf/postpartum-haemorrhage-guideline]
15. Karski JM, Teasdale SJ, Norman P, et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. J Thorac Cardiovasc Surg 1995; 110: 835-42
16. Hayashi M, Fukasawa I, Inaba N. Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies. Int J Clin Pract 2006; 60: 1244-9
17. Conover WJ, Iman RL. Rank transformations as a bridge between parametric and non-parametric statistics. the American Statistician 1981; 35: 124-33
18. Gerbasi FR, Bottoms S, Farag A, Mammen EF. Changes in hemostasis activity during delivery and the immediate postpartum period. Am J Obstet Gynecol 1990; 162: 1158-63
19. Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73: 31-6
20. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29: 125-30
21. Wang M, Lu S, Li S, Shen F. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer. Clin Chim Acta 2013; 425: 176-80
22. Murphy N, Broadhurst DI, Khashan AS, Gilligan O, Kenny LC, O'Donoghue K. Gestation-specific D-dimer reference ranges: A cross-sectional study. BJOG 2015; 122: 395-400
23. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth 2014; 23: 10-7
24. Frith D, Goslings JC, Gaarder C, et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8: 1919-25
25. Ives C, Inaba K, Branco BC, et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 2012; 215: 496-502
26. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64: 1211-7
27. Sawamura A, Hayakawa M, Gando S, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 2009; 124: 608-13
28. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245: 812-8
29. Schöchl H, Voelckel W, Maegele M, Solomon C. Traumaassociated hyperfibrinolysis. Hamostaseologie 2012; 32: 22-7
30. Moore HB, Moore EE, Gonzalez E, et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: The spectrum of postinjuryfibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg 2014; 77: 811-7
31. Raza I, Davenport R, Rourke C, et al. the incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11: 307-14
32. Charbit B, Mandelbrot L, Samain E, et al. the decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73
33. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108: 984-9
34. De Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20: 135-41
35. DowdNP, Karski JM, Cheng DC, et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97: 390-9
36. Shakur H, Elbourne D, G?lmezoglu M, et al. TheWOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010; 11: 40
37. Levy JH. Antifibrinolytic therapy: newdata and newconcepts. Lancet 2010; 376: 3-4
38. Annecke T, Geisenberger T, K?rzl R, Penning R, Heindl B. Algorithm-based coagulation management of catastrophic amniotic fluid embolism. Blood Coagul Fibrinolysis 2010; 21: 95-100
39. Svanberg L, Astedt B, Nilsson IM. Abruptio placentae-treatment with the fibrinolytic inhibitor tranexamic acid. Acta Obstet Gynecol Scand 1980; 59: 127-30
40. Sher G, Statland BE. Abruptio placentae with coagulopathy: A rational basis for management. Clin Obstet Gynecol 1985; 28: 15-23
41. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology 2013; 118: 853-62